A Randomized Controlled Trial to Assess Prophylactic Methylergonovine in Patients Undergoing an Intrapartum Cesarean Section

Overview of attention for article published in American Journal of Obstetrics & Gynecology, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 2 news outlets

twitter: 5 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 35,895 followers.

I’m not an MFM but the topics from #smfm2022 are great learning opportunities for the OBGYN Hospitalist too!

RT @astuebe: First fellow’s plenary: A Randomized Controlled Trial to Assess Prophylactic Methylergonovine in Patients Undergoing an Intra…

RT @drloralei: Loved this! @IowaMed with a simple, solid study that shows that #methergine prophylaxis can improve rates of #PPH and outco…

Loved this! @IowaMed with a simple, solid study that shows that #methergine prophylaxis can improve rates of #PPH and outcomes in unscheduled #cesarean Go #MFMfellows! #smfm22 #maternalmortality #hemmorhage @Andrea37786547 @MelissaWongMD

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.